293480 Stock Chart & Stats
₩8410.00
-₩40.00(-0.47%)
―
--
Day’s Range― - ―
52-Week Range₩8,120.00 - ₩12,390.00
Previous CloseN/A
VolumeN/A
Average Volume (3M)29.63K
Market Cap
₩146.18B
Enterprise Value₩207.31K
Total Cash (Recent Filing)₩17.28B
Total Debt (Recent Filing)₩68.84B
Price to Earnings (P/E)8.6
Beta0.11
Next Earnings
Nov 18, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)982.93
Shares Outstanding17,772,945
10 Day Avg. Volume35,848
30 Day Avg. Volume29,625
Financial Highlights & Ratios
PEG Ratio-0.38
Price to Book (P/B)0.64
Price to Sales (P/S)0.83
P/FCF Ratio-10.04
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
293480 FAQ
What was Hana Pharm Co., Ltd.’s price range in the past 12 months?
Hana Pharm Co., Ltd. lowest stock price was ₩8120.00 and its highest was ₩12390.00 in the past 12 months.
What is Hana Pharm Co., Ltd.’s market cap?
Hana Pharm Co., Ltd.’s market cap is ₩146.18B.
When is Hana Pharm Co., Ltd.’s upcoming earnings report date?
Hana Pharm Co., Ltd.’s upcoming earnings report date is Nov 18, 2026 which is in 87 days.
How were Hana Pharm Co., Ltd.’s earnings last quarter?
Hana Pharm Co., Ltd. released its earnings results on Aug 14, 2026. The company reported ₩476.776 earnings per share for the quarter, missing the consensus estimate of N/A by N/A.
Is Hana Pharm Co., Ltd. overvalued?
According to Wall Street analysts Hana Pharm Co., Ltd.’s price is currently Undervalued.
Does Hana Pharm Co., Ltd. pay dividends?
Hana Pharm Co., Ltd. pays a N/A dividend of ₩260 which represents an annual dividend yield of N/A. See more information on Hana Pharm Co., Ltd. dividends here
What is Hana Pharm Co., Ltd.’s EPS estimate?
Hana Pharm Co., Ltd.’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Hana Pharm Co., Ltd. have?
Hana Pharm Co., Ltd. has 17,772,945 shares outstanding.
What happened to Hana Pharm Co., Ltd.’s price movement after its last earnings report?
Hana Pharm Co., Ltd. reported an EPS of ₩476.776 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went up 1.814%.
Which hedge fund is a major shareholder of Hana Pharm Co., Ltd.?
Currently, no hedge funds are holding shares in KR:293480
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Hana Pharm Co., Ltd.
Hana Pharm Co., Ltd. is a pharmaceutical enterprise that manufactures and supplies a diverse range of medicinal goods to both domestic South Korean and international markets. Its comprehensive product line covers various therapeutic categories, such as anesthetics, potent narcotic pain relievers, anti-nausea agents, muscle relaxants, and treatments targeting the cardiovascular, endocrine, gastrointestinal, respiratory, and central nervous systems. Furthermore, the company offers antibiotics, dermatological preparations, urological medications, osteoporosis therapies, and medications for pain, fever, and inflammation. The firm was established in 1958 and has its corporate headquarters located in Seoul, South Korea.
Dong Wha Pharm Co., Ltd.
―
Samil Pharmaceutical Co., Ltd.
―
SAMSUNG PHARMACEUTICAL.CO.,Ltd.
―
Daewon Pharmaceutical Co., Ltd
―
Jeil Pharmaceutical Co. Ltd.
―